NCT/Study#

MOLECULAR-PROFILING-SAMPLING

Molecular profiling in patients with advanced lung or thymic cancer previously treated with immune checkpoint inhibitor therapy.

Molecular profiling in patients with advanced lung or thymic cancer previously treated with immune checkpoint inhibitor therapy.

DISEASE GROUP:
Phase 1 (Thoracic)
current phase:
NA
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: